Drug prices in TV ads again? Senators take another swing with expedited bill

Sens. Dick Durbin (D-IL) and Chuck Grassley (R-IA) are hoping the third time’s the charm on a bill to force pharma companies to list drug prices in advertising. The two legislators requested an expedited Senate unanimous consent on Tuesday for their co-sponsored Drug-price Transparency for Consumers Act (DTC Act) that Sen. Mike Crapo (R-ID) objected to.

The current bill was reintroduced in April. However, it follows two failed similar efforts by the senators in 2018 and 2020.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Study shows environment’s pivotal role in healthy aging and disease prevention

Study explores new geroscience tools for studying the impact of environmental factors on aging, aiming to delay age-related diseases and disabilities. It highlights how non-genetic

November 14, 2023

North Carolina’s Medicaid program to cover weight loss drugs beginning in August

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 23, 2024

Stem Cell Selection Unneeded for SSc Transplant Therapy?

Autologous stem cell transplant for patients with diffuse systemic sclerosis (SSc), without selecting for a particular hematopoietic cell type, performed about as well in a

December 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.